Back to Results
First PageMeta Content
Bioequivalence / Active ingredient / Pharmaceutical formulation / Food and Drug Administration / Generic drug / Biologic / Ingredient / Alternative medicine / Pharmacology / Pharmaceutical sciences / Clinical research


Interpretation of "Identical Medicinal Ingredient" - Questions and Answers
Add to Reading List

Document Date: 2013-07-12 14:25:51


Open Document

File Size: 40,15 KB

Share Result on Facebook

City

Basel / New York / /

Company

Eli Lilly Canada Inc. / Reddy-Cheminor Inc. / HPFB's / /

Country

Canada / /

Event

FDA Phase / /

IndustryTerm

pharmaceutical equivalence / chemical stereoisomers / chemical identity / chemical identicality / to injectable products / pharmaceutical industry / chemical properties / drug product / authorized product / subsequent entry drug product / reference product / proposed drug product / generic product / chemical entity-type drug submissions / entry product / proposed generic drug product / hydration products / biological and radiopharmaceutical products / subsequent entry drug products / chemical entity / chemical structure / generic drug products / chemical constituents / drug products / similar medicinal product / /

Organization

European Commission / FDA / office of Patented Medicines and Liaison / /

Person

Marcel Dekker / David J.W. Grant / /

Position

Official / Prime Minister / Minister / Minister of Health / Attorney General / /

Product

Chiral Drug / Cipro / Ciprofloxacin / substance / /

ProgrammingLanguage

EC / /

ProvinceOrState

New York / /

PublishedMedium

the Official Journal / /

Technology

pharmacokinetics / Drug Development / /

SocialTag